The stock has a 36-month beta value of 2.12. Opinions on the stock are mixed, with 1 analysts rating it as a “buy”, 0 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for COCH is 17.65M, and at present, short sellers hold a 2.44% of that float. On February 12, 2026, the average trading volume of COCH was 281.19K shares.
COCH stock’s latest price update
Envoy Medical Inc (NASDAQ: COCH)’s stock price has plunge by 69.20%relation to previous closing price of $0.39. Nevertheless, the company has seen a 14.69% surge in its stock price over the last five trading sessions.
COCH’s Market Performance
Envoy Medical Inc (COCH) has seen a 14.69% rise in stock performance for the week, with a -7.35% decline in the past month and a -5.76% plunge in the past quarter. The volatility ratio for the week is 41.62%, and the volatility levels for the past 30 days are at 14.43% for COCH. The simple moving average for the past 20 days is 6.43% for COCH’s stock, with a -40.51% simple moving average for the past 200 days.
Analysts’ Opinion of COCH
Many brokerage firms have already submitted their reports for COCH stocks, with Ascendiant Capital Markets repeating the rating for COCH by listing it as a “Buy”. The predicted price for COCH in the upcoming period, according to Ascendiant Capital Markets is $8.50 based on the research report published on June 24, 2024 of the previous year 2024.
COCH Trading at -4.98% from the 50-Day Moving Average
After a stumble in the market that brought COCH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.46% of loss for the given period.
Volatility was left at 14.43%, however, over the last 30 days, the volatility rate increased by 41.62%.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COCH starting from Patel Mona Chetan, who purchase 2,500 shares at the price of $1.47 back on Jun 11 ’25. After this action, Patel Mona Chetan now owns 20,000 shares of Envoy Medical Inc, valued at $3,675 using the latest closing price.
Patel Mona Chetan, the Director of Envoy Medical Inc, purchase 10,000 shares at $1.46 during a trade that took place back on Jun 06 ’25, which means that Patel Mona Chetan is holding 17,500 shares at $14,600 based on the most recent closing price.
Stock Fundamentals for COCH
Current profitability levels for the company are sitting at:
- -98.12% for the present operating margin
- -2.94% for the gross margin
The net margin for Envoy Medical Inc stands at -104.75%. The total capital return value is set at 25.29%.
Based on Envoy Medical Inc (COCH), the company’s capital structure generated -0.14 points at debt to capital in total, while cash flow to debt ratio is standing at -17.87. The debt to equity ratio resting at -0.13. The interest coverage ratio of the stock is -10.34.
Currently, EBITDA for the company is -$19.81 million with net debt to EBITDA at 0.13. When we switch over and look at the enterprise to sales, we see a ratio of 53.42. The receivables turnover for the company is 5.94for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.64.
Conclusion
To sum up, Envoy Medical Inc (COCH) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.